TABLE 2.
Entire cohort |
Women |
Men |
||||||||||
Baseline multivariate analysis2 |
Longitudinal multivariate3 analysis |
Baseline multivariate analysis4 |
Longitudinal multivariate analysis5 |
Baseline multivariate analysis4 |
Longitudinal multivariate analysis5 |
|||||||
β | P | β | P | β | P | β | P | β | P | β | P | |
Cohort | ||||||||||||
Zinc, mg/L | −0.63 ± 0.25 | 0.011 | −0.37 ± 0.17 | 0.033 | −0.53 ± 0.27 | 0.054 | −0.24 ± 0.16 | 0.126 | −0.76 ± 0.35 | 0.033 | −0.43 ± 0.24 | 0.073 |
Zinc deficiency6 | −0.44 ± 0.14 | 0.002 | 0.38 ± 0.12 | 0.001 | −0.34 ± 0.16 | 0.043 | 0.08 ± 0.10 | 0.002 | −0.53 ± 0.20 | 0.008 | 0.52 ± 0.17 | 0.002 |
HIV monoinfected | ||||||||||||
Zinc, mg/L | −0.01 ± 0.202 | 0.98 | −0.06 ± 0.16 | 0.70 | −0.06 ± 0.17 | 0.72 | −0.11 ± 0.10 | 0.29 | 0.05 ± 0.29 | 0.87 | −0.07 ± 0.22 | 0.76 |
Zinc deficiency6 | −0.01 ± 0.125 | 0.97 | 0.27 ± 0.13 | 0.038 | −0.01 ± 0.11 | 0.96 | 0.07 ± 0.07 | 0.34 | −0.02 ± 0.18 | 0.93 | 0.33 ± 0.18 | 0.066 |
HIV/HCV coinfected | ||||||||||||
Zinc, mg/L | −2.38 ± 0.72 | 0.001 | −1.79 ± 0.58 | 0.003 | −1.17 ± 0.82 | 0.16 | −0.36 ± 0.56 | 0.53 | −3.62 ± 1.17 | 0.003 | −3.23 ± 0.94 | 0.001 |
Zinc deficiency6 | −0.70 ± 0.32 | 0.031 | 0.53 ± 0.26 | 0.045 | −0.44 ± 0.38 | 0.25 | −0.03 ± 0.25 | 0.92 | −0.84 ± 0.48 | 0.086 | 0.90 ± 0.42 | 0.036 |
Values are means ± SEs, n = 487. FIB-4 was calculated with the use of the following formula: [age (years) × AST (U/L)]/[PLT (109 cells/L) × ALT1/2(U/L)]. ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUDIT, Adult Use Disorders Identification Test; FIB-4, fibrosis-4; HCV, hepatitis C virus; PLT, platelet count.
Analyses conducted with the use of linear and logistic regression. All models were adjusted for sex, race, BMI, CD4 cell count, HIV viral load, AUDIT, and tobacco use.
Analysis conducted with the use of mixed models. All models were adjusted for sex, race, BMI, CD4 cell count, HIV viral load, AUDIT, and tobacco use.
Analyses conducted with the use of linear and logistic regression. All models were adjusted for race, BMI, CD4 cell count, HIV viral load, AUDIT, and tobacco use.
Analysis conducted with the use of mixed models. All models were adjusted for race, BMI, CD4 cell count, HIV viral load, AUDIT, and tobacco use.
Defined as plasma zinc concentration <0.75 mg/L.